Cystic Fibrosis SNOMED

Codelist metadata

Coding system
SNOMED CT (UK Clinical Edition)
Coding system release
40.2.0
Organisation
OpenSAFELY
Codelist ID
opensafely/cystic-fibrosis-snomed
Version ID
1eb02212
Number of codes included
58

Versions

About

Description

This codelist defines cystic fibrosis and is designed for specificity.
It was developed for the vitamin D study.

Methodology

Search term: cystic fibrosis All active and inactive SNOMED codes were reviewed.

Inclusion criteria: Codes indicating a confirmed diagnosis of cystic fibrosis, including codes for any conditions due to complications of cystic fibrosis and the codes for cystic fibrosis review/ monitoring.

Exclusion criteria for codes: Codes relating to screening, family history, being a carrier, inconclusive diagnosis (suspected CF), CF-transporter-related conditions, medications acting via CF transporer, or being seen in CF clinic (as possibly patients with inconclusive diagnosis can be seen).

References

Signed off by

  • Arina Tamborska, (July 21, 2025)
  • Andrew Brown, (Aug. 4, 2025)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
1010616001 Cirrhosis of liver due to classical cystic fibrosis
1296527009 Cystic fibrosis due to heterozygous deltaF508 mutation
1296528004 Cystic fibrosis due to homozygous deltaF508 mutation
154767009 Cystic fibrosis
190905008 Cystic fibrosis
190906009 Cystic fibrosis with no meconium ileus
190907000 Meconium ileus in cystic fibrosis
190908005 Cystic fibrosis with pulmonary manifestations
190909002 Cystic fibrosis with intestinal manifestations
190910007 Cystic fibrosis with other manifestations
190911006 Cystic fibrosis NOS
206471004 Perinatal jaundice due to mucoviscidosis
235978006 Cystic fibrosis of pancreas
286451000000100 Cystic fibrosis related diabetes mellitus
292571000000107 Cystic fibrosis related diabetes mellitus
307732006 Cystic fibrosis with other manifestations
426705001 Diabetes mellitus co-occurrent and due to cystic fibrosis
427022004 Liver disease due to cystic fibrosis
427089005 Diabetes mellitus due to cystic fibrosis
515611000000104 Cystic fibrosis monitoring
515621000000105 Cystic fibrosis monitoring
515631000000107 Cystic fibrosis annual review
515641000000103 Cystic fibrosis annual review
526071000000104 Arthropathy in cystic fibrosis
526091000000100 Cystic fibrosis with distal intestinal obstruction syndrome
526101000000108 Liver disease due to cystic fibrosis
604421000000104 Cystic fibrosis NOS
658391000000105 Cystic fibrosis with other manifestations
698940002 Arthropathy associated with cystic fibrosis
706991000000106 Arthropathy in cystic fibrosis
707001000000100 Cystic fibrosis with distal intestinal obstruction syndrome
707011000000103 Liver disease due to cystic fibrosis
707418001 Male infertility due to cystic fibrosis
707419009 Osteoporosis due to cystic fibrosis
707420003 Portal hypertension due to cystic fibrosis
707450006 Pancreatic insufficiency due to cystic fibrosis of pancreas
707536003 Digestive system manifestation co-occurrent and due to cystic fibrosis
707542004 Otorhinolaryngological manifestation co-occurrent and due to cystic fibrosis
707577004 Female infertility due to cystic fibrosis
707578009 Perforation of intestine due to cystic fibrosis with meconium ileus
707734002 Liver enzymes level above reference range due to cystic fibrosis
707766007 Exocrine pancreatic manifestation co-occurrent and due to cystic fibrosis
716088000 Follicular hamartoma with alopecia and cystic fibrosis syndrome
720401009 Cystic fibrosis with gastritis and megaloblastic anemia syndrome
721197001 Polyneuropathy due to classical cystic fibrosis
725052002 Fetal cystic fibrosis
762269004 Classical cystic fibrosis
762270003 Atypical cystic fibrosis
762271004 Subclinical cystic fibrosis
776981000000103 Cirrhosis associated with cystic fibrosis
778131000000103 Cystic fibrosis related cirrhosis
81423003 Cystic fibrosis without meconium ileus
817966005 Distal intestinal obstruction syndrome due to cystic fibrosis
85809002 Cystic fibrosis
859041000000103 Exacerbation of cystic fibrosis
859051000000100 Exacerbation of cystic fibrosis
86092005 Cystic fibrosis with meconium ileus
86555001 Cystic fibrosis of the lung

This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.

cystic fibrosis

Included 58 out of 204 matching concepts.

Show matching concepts
  • (Fetus with hereditary disease) or (cystic fibrosis in pregnancy) (156177002)
  • (Fetus with hereditary disease) or (cystic fibrosis in pregnancy) (267334004)
  • Adult cystic fibrosis care plan (959821000000108)
  • Adult cystic fibrosis service (893391000000101)
  • Arthropathy associated with cystic fibrosis (698940002)
  • Arthropathy in cystic fibrosis (706991000000106)
  • Arthropathy in cystic fibrosis (526071000000104)
  • Atypical cystic fibrosis (762270003)
  • Azoospermia with absent vasa in association with cystic fibrosis trait (236793007)
  • Carrier of cystic fibrosis gene (777381000000100)
  • Carrier of cystic fibrosis gene mutation (441520002)
  • Cirrhosis associated with cystic fibrosis (776981000000103)
  • Cirrhosis of liver due to classical cystic fibrosis (1010616001)
  • Classical cystic fibrosis (762269004)
  • Cystic fibrosis (190905008)
  • Cystic fibrosis (154767009)
  • Cystic fibrosis (85809002)
  • Cystic fibrosis 20 common mutation test (382241000000108)
  • Cystic fibrosis 29 common mutation test (382251000000106)
  • Cystic fibrosis NOS (604421000000104)
  • Cystic fibrosis NOS (190911006)
  • Cystic fibrosis annual review (515631000000107)
  • Cystic fibrosis annual review (515641000000103)
  • Cystic fibrosis carrier comment (302651000000109)
  • Cystic fibrosis carrier detection (44489000)
  • Cystic fibrosis carrier detection, amniotic fluid (69103000)
  • Cystic fibrosis carrier detection, blood (41636009)
  • Cystic fibrosis clinic (702844004)
  • Cystic fibrosis due to heterozygous deltaF508 mutation (1296527009)
  • Cystic fibrosis due to homozygous deltaF508 mutation (1296528004)
  • Cystic fibrosis food (328285005)
  • Cystic fibrosis gene carrier (807631000000102)
  • Cystic fibrosis gene carrier (384301000000109)
  • Cystic fibrosis monitoring (515611000000104)
  • Cystic fibrosis monitoring (515621000000105)
  • Cystic fibrosis not screened for or screening incomplete, baby died (947531000000103)
  • Cystic fibrosis not screened for or screening incomplete, baby died (947541000000107)
  • Cystic fibrosis not screened for or screening incomplete, moved out of area (947491000000103)
  • Cystic fibrosis not screened for or screening incomplete, moved out of area (947501000000109)
  • Cystic fibrosis not screened for or screening incomplete, not contactable, reasonable efforts made (947511000000106)
  • Cystic fibrosis not screened for or screening incomplete, not contactable, reasonable efforts made (947521000000100)
  • Cystic fibrosis not screened for or screening incomplete, not required, previous valid result (965271000000100)
  • Cystic fibrosis not screened for or screening incomplete, not required, previous valid result (947551000000105)
  • Cystic fibrosis not screened for or screening incomplete: more than 8 weeks, too old for screening (947401000000105)
  • Cystic fibrosis not screened for or screening incomplete: more than 8 weeks, too old for screening (947411000000107)
  • Cystic fibrosis not suspected (302461000000109)
  • Cystic fibrosis not suspected (428273001)
  • Cystic fibrosis not suspected (831201000000107)
  • Cystic fibrosis of pancreas (235978006)
  • Cystic fibrosis of the lung (86555001)
  • Cystic fibrosis related cirrhosis (778131000000103)
  • Cystic fibrosis related diabetes mellitus (292571000000107)
  • Cystic fibrosis related diabetes mellitus (286451000000100)
  • Cystic fibrosis respiratory culture (117254004)
  • Cystic fibrosis screening (148406000)
  • Cystic fibrosis screening (171191008)
  • Cystic fibrosis screening (1028351000000108)
  • Cystic fibrosis screening declined (302211000000108)
  • Cystic fibrosis screening declined (428841003)
  • Cystic fibrosis screening declined (875541000000109)
  • Cystic fibrosis screening declined, no history of being screened (947031000000109)
  • Cystic fibrosis screening declined, no history of being screened (965681000000100)
  • Cystic fibrosis screening declined, screened in UK (as reported by parents) with no evidence of result (947051000000102)
  • Cystic fibrosis screening declined, screened in United Kingdom (as reported by parents) with no evidence of result (947041000000100)
  • Cystic fibrosis screening declined, screened outside UK with evidence of result (947071000000106)
  • Cystic fibrosis screening declined, screened outside UK with no evidence of result (947091000000105)
  • Cystic fibrosis screening declined, screened outside United Kingdom with evidence of result (947061000000104)
  • Cystic fibrosis screening declined, screened outside United Kingdom with no evidence of result (947081000000108)
  • Cystic fibrosis screening related finding (946741000000101)
  • Cystic fibrosis screening related finding (946751000000103)
  • Cystic fibrosis screening test (144405008)
  • Cystic fibrosis screening test (314080004)
  • Cystic fibrosis screening test (167167007)
  • Cystic fibrosis screening test (1015871000000108)
  • Cystic fibrosis screening, inconclusive result (947381000000105)
  • Cystic fibrosis screening, inconclusive result (947391000000107)
  • Cystic fibrosis screening, insufficient sample (947141000000104)
  • Cystic fibrosis screening, insufficient sample (947151000000101)
  • Cystic fibrosis screening, too young for reliable screening (947101000000102)
  • Cystic fibrosis screening, too young for reliable screening (947111000000100)
  • Cystic fibrosis screening, unsuitable sample (blood quality): compressed/damaged (947181000000107)
  • Cystic fibrosis screening, unsuitable sample (blood quality): compressed/damaged (947191000000109)
  • Cystic fibrosis screening, unsuitable sample (blood quality): incorrect blood application (947161000000103)
  • Cystic fibrosis screening, unsuitable sample (blood quality): incorrect blood application (947171000000105)
  • Cystic fibrosis screening, unsuitable sample: more than 14 days in transit, too old for analysis (947351000000104)
  • Cystic fibrosis screening, unsuitable sample: NHS number missing/not accurately recorded (947251000000107)
  • Cystic fibrosis screening, unsuitable sample: National Health Service number missing/not accurately recorded (947241000000109)
  • Cystic fibrosis screening, unsuitable sample: damaged in transit (947361000000101)
  • Cystic fibrosis screening, unsuitable sample: damaged in transit (947371000000108)
  • Cystic fibrosis screening, unsuitable sample: date of birth not accurately matched (947301000000100)
  • Cystic fibrosis screening, unsuitable sample: date of birth not accurately matched (947311000000103)
  • Cystic fibrosis screening, unsuitable sample: date of sample missing/not accurately recorded (947281000000101)
  • Cystic fibrosis screening, unsuitable sample: date of sample missing/not accurately recorded (947291000000104)
  • Cystic fibrosis screening, unsuitable sample: day 0 and day 5 on same card (947201000000106)
  • Cystic fibrosis screening, unsuitable sample: day 0 and day 5 on same card (947211000000108)
  • Cystic fibrosis screening, unsuitable sample: expired card used (947321000000109)
  • Cystic fibrosis screening, unsuitable sample: expired card used (947331000000106)
  • Cystic fibrosis screening, unsuitable sample: more than 14 days in transit, too old for analysis (947341000000102)
  • Cystic fibrosis screening, unsuitable sample: possible faecal contamination (947221000000102)
  • Cystic fibrosis screening, unsuitable sample: possible faecal contamination (947231000000100)
  • Cystic fibrosis screening,sample taken too soon after blood transfusion (less than 72 hours) (947121000000106)
  • Cystic fibrosis screening,sample taken too soon after transfusion (more than 72 hours) (947131000000108)
  • Cystic fibrosis sweat test (86964003)
  • Cystic fibrosis transmembrane conductance regulator comprehensive genetic test (925131000000100)
  • Cystic fibrosis transmembrane conductance regulator linkage genetic test (925071000000102)
  • Cystic fibrosis transmembrane conductance regulator potentiator (735969005)
  • Cystic fibrosis transmembrane conductance regulator single mutation genetic test (925081000000100)
  • Cystic fibrosis transmembrane conductance regulator targeted genetic test (925091000000103)
  • Cystic fibrosis transmembrane conductance regulator-related disorder (1335845008)
  • Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome (16434671000119101)
  • Cystic fibrosis with distal intestinal obstruction syndrome (707001000000100)
  • Cystic fibrosis with distal intestinal obstruction syndrome (526091000000100)
  • Cystic fibrosis with gastritis and megaloblastic anemia syndrome (720401009)
  • Cystic fibrosis with intestinal manifestations (190909002)
  • Cystic fibrosis with meconium ileus (86092005)
  • Cystic fibrosis with no meconium ileus (190906009)
  • Cystic fibrosis with other manifestations (658391000000105)
  • Cystic fibrosis with other manifestations (307732006)
  • Cystic fibrosis with other manifestations (190910007)
  • Cystic fibrosis with pulmonary manifestations (190908005)
  • Cystic fibrosis without meconium ileus (81423003)
  • Cystic fibrosis, prenatal detection (67799006)
  • Diabetes mellitus co-occurrent and due to cystic fibrosis (426705001)
  • Diabetes mellitus due to cystic fibrosis (427089005)
  • Digestive system manifestation co-occurrent and due to cystic fibrosis (707536003)
  • Distal intestinal obstruction syndrome due to cystic fibrosis (817966005)
  • Elexacaftor (827070004)
  • Emergency hospital admission to adult cystic fibrosis service (1079211000000107)
  • Emergency hospital admission to paediatric cystic fibrosis service (1079191000000108)
  • Exacerbation of cystic fibrosis (859041000000103)
  • Exacerbation of cystic fibrosis (859051000000100)
  • Exocrine pancreatic manifestation co-occurrent and due to cystic fibrosis (707766007)
  • FH: Cystic fibrosis (137711004)
  • Family history of cystic fibrosis (160309002)
  • Female infertility due to cystic fibrosis (707577004)
  • Fetal cystic fibrosis (725052002)
  • Fetus with chromosomal abnormality (& suspect: [CF] or [mongol]) (199524005)
  • Follicular hamartoma with alopecia and cystic fibrosis syndrome (716088000)
  • Ivacaftor (776434000)
  • Ivacaftor (703823007)
  • Ivacaftor + Tezacaftor + Elexacaftor (827103004)
  • Liver disease due to cystic fibrosis (526101000000108)
  • Liver disease due to cystic fibrosis (707011000000103)
  • Liver disease due to cystic fibrosis (427022004)
  • Liver enzymes level above reference range due to cystic fibrosis (707734002)
  • Lumacaftor (716073005)
  • Lumacaftor + Ivacaftor (776435004)
  • Male infertility due to cystic fibrosis (707418001)
  • Meconium ileus in cystic fibrosis (190907000)
  • Newborn blood spot screening programme - cystic fibrosis not screened for or screening incomplete (874641000000107)
  • Newborn blood spot screening programme - cystic fibrosis not suspected and other disorders follow up required (874661000000108)
  • Newborn blood spot screening programme - cystic fibrosis repeat screening with further sample required (874651000000105)
  • Newborn blood spot screening programme, cystic fibrosis further sample required (302281000000101)
  • Newborn blood spot screening programme, cystic fibrosis not screened for or screening incomplete (302771000000109)
  • Newborn blood spot screening programme, cystic fibrosis not suspected and other disorders follow up required (384401000000104)
  • Newborn blood spot screening programme, cystic fibrosis not suspected further follow up required (302551000000105)
  • Newborn blood spot screening programme, cystic fibrosis repeat screening with further sample required (384341000000107)
  • Osteoporosis due to cystic fibrosis (707419009)
  • Otorhinolaryngological manifestation co-occurrent and due to cystic fibrosis (707542004)
  • Paediatric cystic fibrosis care plan (959001000000108)
  • Paediatric cystic fibrosis service (827981000000103)
  • Pancreatic insufficiency due to cystic fibrosis of pancreas (707450006)
  • Perforation of intestine due to cystic fibrosis with meconium ileus (707578009)
  • Perinatal jaundice due to mucoviscidosis (206471004)
  • Polyneuropathy due to classical cystic fibrosis (721197001)
  • Portal hypertension due to cystic fibrosis (707420003)
  • Product containing cystic fibrosis transmembrane conductance regulator potentiator (764133002)
  • Product containing elexacaftor and ivacaftor and tezacaftor (827101002)
  • Product containing elexacaftor and ivacaftor and tezacaftor in oral dose form (827102009)
  • Product containing ivacaftor (703824001)
  • Product containing ivacaftor and lumacaftor (763602007)
  • Product containing ivacaftor and lumacaftor in oral dose form (764335004)
  • Product containing ivacaftor and tezacaftor (771671009)
  • Product containing ivacaftor and tezacaftor in oral dose form (771673007)
  • Product containing ivacaftor in oral dose form (772541005)
  • Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form (827104005)
  • Product containing only ivacaftor and lumacaftor in oral dose form (779618006)
  • Product containing only ivacaftor and tezacaftor in oral dose form (779619003)
  • Product containing only ivacaftor in oral dose form (779620009)
  • Product containing precisely elexacaftor 100 milligram and ivacaftor 75 milligram and tezacaftor 50 milligram/1 each conventional release oral tablet (1303888001)
  • Product containing precisely elexacaftor 50 milligram and ivacaftor 37.5 milligram and tezacaftor 25 milligram/1 each conventional release oral tablet (1303887006)
  • Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (1332199007)
  • Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet (703825000)
  • Product containing precisely ivacaftor 25 milligram/1 sachet conventional release oral granules (1260297003)
  • Product containing precisely ivacaftor 50 milligram/1 sachet conventional release oral granules (1260296007)
  • Product containing precisely ivacaftor 75 milligram and tezacaftor 50 milligram/1 each conventional release oral tablet (1332200005)
  • Product containing precisely ivacaftor 75 milligram/1 each conventional release oral tablet (1287111000)
  • Product containing precisely ivacaftor 75 milligram/1 sachet conventional release oral granules (1260299000)
  • Screen for 20 common genetic mutations of cystic fibrosis using amplification refractory mutation system polymerase chain reaction assay technique (444260001)
  • Screen for 29 common genetic mutations of cystic fibrosis using amplification refractory mutation system polymerase chain reaction assay technique (443530000)
  • Seen in cystic fibrosis clinic (709831000000109)
  • Seen in cystic fibrosis clinic (698529000)
  • Seen in cystic fibrosis clinic (709841000000100)
  • Subclinical cystic fibrosis (762271004)
  • Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action (736948000)
  • Suspect cystic fibrosis fetus (237151009)
  • Suspected cystic fibrosis (428301001)
  • Suspected cystic fibrosis (302401000000105)
  • Suspected cystic fibrosis (875681000000100)
  • Suspected cystic fibrosis in fetus (725051009)
  • Tezacaftor (771596001)
  • Tezacaftor + Ivacaftor (776436003)
  • [V]Screening for cystic fibrosis (316649006)
  • [V]Screening for cystic fibrosis (466821000000105)